Appropriate Laboratory Testing for Toxic Metals

Similar documents
David Quig, PhD Doctor s Data, Inc.

The Weight of the Evidence: The Role of Chelation in the Treatment of Arsenic and Mercury Poisoning

Elemental analysis in clinical practice

Mercury and The Human Detoxification System

TOXIC AND ESSENTIAL ELEMENTS

Dimercapto-1-propanesulfonic Acid (DMPS)

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

AN EPIGENETIC MODEL OF AUTISM AND A WARNING REGARDING RISPERDAL. William J. Walsh, Ph.D. Walsh Research Institute Naperville, IL

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Pro-Oxidant Environmental Exposures: Implications of Redox Imbalance in Autism S. Jill James, Ph.D.

Toxic Metals As Endocrine Disruptors

METAL IMBALANCES IN AUTISM BRAIN TISSUES

Trace Elements & Lecture outline METALS USED IN THERAPY ESSENTIAL METALS. Which elements? Essential elements: Cu, Zn, Se

Aging and nutrition 03/11/2012. Why do people age? Oxidative stress and damage

IVC History, Cancer Research

Case Study 2 Answers Spring 2006

ROS as targets for therapeutic intervention of diabetic nephropathy

NST 160 Theil Selenium Lecture 1 October 27, 2004 Selenium Nutrition and Physiology

The Scientific Basis for Chelation: Animal Studies and Lead Chelation

Speaker: Paul De Smet. Thursday June 4th 2015

Principles of Toxicology: The Study of Poisons

Neuropathy Following Chronic Use of Denture Adhesive in 40-Year-Old Patient (printer-friendly)

INFLUENCE OF MELATONIN ON ARSENIC MEDIATED PANCREATIC DAMAGE IN SWISS ALBINO MICE

Osnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,

Cystatin C: A New Approach to Improve Medication Dosing

BASIC PHARMACOKINETICS

Assessing Renal Function: What you Didn t Know You Didn t Know

Epigenetics and Autism Prevention

BIOPHARMACEUTICS and CLINICAL PHARMACY

TOXIC METALS RESULT REFERENCE WITHIN µg/g creat INTERVAL REFERENCE OUTSIDE REFERENCE

SUMMARY AND CONCLUSION

Lead Neurotoxicity. Current Status and New Approaches. Stephen M. Lasley, Ph.D.

MITOCHONDRIAL FUNCTION & RELATED TESTS

Kalish Method Functional Mdii Medicine Training i Program Dr. Dan Kalish

AMINOGLYCOSIDES TDM D O N E B Y

Dr.Nahid Osman Ahmed 1

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

INTEGRATIVE/ENVIRONMENTAL MEDICINE STANDARD OF CARE GUIDELINES FOR INCREASED TOTAL BODY BURDEN OF TOXIC METALS

Biology 137 Introduction to Toxicology Name Midterm Exam 1 Fall Semester 2001

Metal Detoxification

The Biochemistry of Detoxification. David Quig, PhD

Click to edit Master title style

Renal Function and Associated Laboratory Tests

Acute Kidney Injury. I. David Weiner, M.D. Division of Nephrology, Hypertension and Transplantation University of Florida and NF/SGVHS

!!"#$%&'!())*+,$-.&(.*/*+,)0&1-$2

BACKGROUND Measuring renal function :

THE COLLISION OF UNDERMETHYLATION, EPIGENETICS, AND OXIDATIVE STRESS IN AUTISM SPECTRUM DISORDERS

DRUG DISTRIBUTION. Distribution Blood Brain Barrier Protein Binding

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

2. List routes of exposure in the order of most rapid response.

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Principal Investigator: Marion, Alan, S, M.D., MDS Pharma Services (US) Inc., 621 Rose Street, PO Box 80837, Lincoln, NE 68502, USA

Metals in Redox Biology C O R Y B O O N E, C E C I L I A H A G E R T, Q I A N G MA R E D O X - C O U R S E

General Principles of Pharmacology and Toxicology

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology

Cysteine Peptide Scientific Review, Dr. S. Dudek, DMV International

For more information about Thomson Reuters Micromedex, visit Information valid as of March 17, 2011.

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

American Journal of Human Genetics. American Journal of Hypertension. American Journal of Neuroradiology

Mechanism of Detoxification

Drug dosing in Extremes of Weight

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

HIHIM 409 7/26/2009. Kidney and Nephron. Fermamdo Vega, M.D. 1

Hompes Method. Practitioner Training Level II. Lesson Fifteen Heavy Metal Cases

Non-protein nitrogenous substances (NPN)

TOXIC EFFECTS OF METALS

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

MULTI-COMPONENT ANALYSIS OF HEAVY METALS

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

An In Vitro Alternative For Predicting Systemic Toxicity. By: James McKim, Ph.D., DABT Chief Science Officer

TDM of Aminoglycoside Antibiotics

Glycinates Animal Nutrition G-ENL/MT, G-ENL/MP

Porphyrin testing and heavy metal toxicity: unresolved questions and concerns

Introduction to Clinical Diagnosis Nephrology

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Mike Hinds, Royal Canadian Mint

Cysteine Supplementation in Parenteral-fed Critically ill Neonates:

Pharmacokinetics Overview

HAIR ELEMENTS. LAB#: PATIENT: SEX: Female AGE: 38 CLIENT#:

Research Article The Severity of Autism Is Associated with Toxic Metal Body Burden and Red Blood Cell Glutathione Levels

Ch 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM

Published in the Journal of Human Virology, January/February, 2002, Volume 5, Number 1.

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

White Paper: FDA Update/Review of Potential Adverse Health Risks Associated with Exposure to Mercury in Dental Amalgam

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

PHARMACOKINETICS OF DRUG ABSORPTION

International Journal of Innovative Pharmaceutical Sciences and Research

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

EXPLORING THE MYSTERIES OF AUTISM

Keeping your kidneys young

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Use of PBPK in simulating drug concentrations in pediatric populations: Case studies of Midazolam and Gabapentin

Acid & Alkaline Nutrition: Shattering the Myths By Michael McEvoy, FDN, CNC, CMTA

PHARMACOLOGY-1 PHL-313. Ali Alhoshani Office: 2B 84

Make an appointment with your doctor if you have any signs or symptoms of acute kidney failure.

Using Integrative Medicine to Treat Environmental Toxicity - Toxicity Mastery Course Overview

2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING

2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY

Transcription:

Appropriate Laboratory Testing for Toxic Metals David Quig, PhD Doctor s Data, Inc. Exposure to Toxic Metals Metals Adversely Affect Every Organ System Neurotoxic (ASD, ADHD, PD, Alzhiemers) Cardiovascular Disease Dysregulation of Immune System Dysregulation of Immune System Compromise Gastrointestinal Integrity Nephrotoxic Carcinogenic Doctor s Data 1

Environmental Toxins W.H.O. 30-40% of childhood illnesses associated with environmental toxins C.D.C. The epidemic of epidemics of CVD and immunological and neurological disease is likely associated with environmental toxins Nutritional Status Toxic Metals Toxic Metals Gastrointestinal Function Immune Function General Mechanisms for Toxicity of Metals Pro-oxidative (lipid peroxides, R-OH) Inhibit antioxidative enzymes SOD (Cu, Zn, Mn), GSH-px (Se) Deplete glutathione (GSH) Direct binding/irreversible excretion Inhibit GSH synthetase/reductase Disrupt protein metabolism and ion homeostasis Doctor s Data 2

TOXIC METALS OXIDATIVE STRESS INFLAMMATION Glutathione λ glutamylcysteinylglycine SH Intracellular Protective Functions Antioxidant (redox state) Conjugation of metals and chemicals Activation of immune function Inhibit replication of retroviruses Proc. Nat. Acad. Sci. (1997) 94 AIDS Res. Hum. Retrovir. (1992) 8 Immunology (1967) 61 Depletion of GSH with: Metal Toxicity Chemical toxicity CVD Diabetes Cancer Neurological diseases Extreme exercise Aging Radiation Exposure Chronic stress Anxiety Chronic fatigue Autism Drugs J Neurol Sci(2008)[Epub] AJCN(2004)80:1611 Prostaglandins Leukot Fatty Acids(2002)67:341 J Lab Clin Med(1992)120 Clin Chim Acta(2003)333:19 Doctor s Data 3

RBC Total Glutathione (900-1,900) ~ 30% below minimum Find source of oxidative stress Support intracellular GSH (e.g. whey protein, oral liposomal GSH, iv GSH, N-AC) Oxidative Damage to DNA: 8-OH-2 -deoxyguanosine (8OHdG) ** 3X > oxidized DNA than average First AM urine void or 24 hr. DNA Oxidative Damage and Environmental As 10-12 yo students, 2 schools (n 50 each) School A: adjacent to, and downwind of 8 power plants, B: upwind, suburban areas School Urine A B As ( g/gm) 21 (4) 10 (1) 8-OHdG (ng/gm) 19 (2) 8 (1) Env. Hlth. Persp. (2005)113: 1186 90 Doctor s Data 4

Oxidative Stress, Metals Exposure 50 yo male, hypertension RBC GSH= 652 (900-1,900 ųmoles/l) 8-OHdG= 26.1 (< 8.5 ng/mg cr) Blood Metals Cd = 8.2 (< 4 ųg/l) Hg = 3.6 (< 2 ųg/l) Pb = 2.7 (< 2 ųg/l) Smoker, 18 amalgams DoctorsData, Inc. Basic Toxicology Exposure Assimilation Retention Toxicity Chronic Metal Toxicity Exposure Assimilation Retention Toxicity NOT generally accepted as requiring treatment Sub clinical metal toxicity Doctor s Data 5

Chronic Metal Toxicity Sub-clinical metal toxicity = sub-threshold For a given individual, toxicity is exhibited when the level of net retention exceeds physiological tolerance. Net Retention Relative rates of assimilation and excretion. Excretion is highly variable and determined by protein expression (GSH, MT), nutritional status, antibiotic use, life style, and total toxic load. Assessment of Exposure: Hair Excretory tissue that binds circulating metals Concentrates metals cumulatively Hair Me-Hg 200-300X > than blood Hg Useful for recent/ongoing EXPOSURE Arch Environ Hlth (1980) atsdr.cdc.gov/hav/hairanalysis/6.2htm Doctor s Data 6

Pubic Hair Metals: Machinist / Welder Sb, As Cd, Pb Machinist / Welder (cont d) ( Mn, Cr, Mo, Co, Fe) * * * Assessment of Exposure: Blood Recent or ongoing exposure Toxicokinetic models; shortest T 1/2 NO indication of net retention Standard of care is still blood Pb Goyer RA et al. Environ Hlth Perspect (1995)103:1048 52 Doctor s Data 7

Fish 3X / week ** Unprovoked Urine: As Exposure Organic As +5 rapidly excreted w/in 48 hrs. of consumption of shellfish PREVENT ALARMISM! Do pre- and post urinalysis initially, and abstain from fish and shellfish a week prior to provocative challenges. Unprovoked 1st AM Urine As = 1,930 g/gm All You Can Eat Crab Fest Doctor s Data 8

For Your Quiver The measurement of lead excreted in urine following an injection of Ca Na 2 EDTA has been used to detect elevated body burden of lead in adults (2,3,4,5) and children (6,7), and is considered to be a reliable measure of the potentially toxic fraction of the lead body burden (8). www.atsdr.cdc.gov/toxprofiles/tp13.html# Assessment of Retention The precedent has been set, assess the net retention of metals using EDTA, DMPS or DMSA Pre- vs. Post-provocation urinary metals (1) objective assessment of body burden (2) legal/medical board considerations Monitor efficacy with identical challenges after 5-10 treatments Pharmacological Provocations Extracellular, aqueous compartments Do NOT appreciably cross a healthy BBB Ca-EDTA, DMPS & DMSA provocations do not directly reflect retention ti in the CNS Significant kidney flush J Pediatr(1997)130:966 71 Occup Environ Med (1995)52:13 19 Fund Appl Toxicol(1995)25:233 40 J Pharmacol Exp Ther (1987)243:804 3 Doctor s Data 9

Evaluations Prior to Provocation Blood chemistries (e.g.cbc w/ differential, creatinine, BUN, liver enzymes) Oral DMSA / DMPS GI symptoms Comprehensive Stool Analysis DOCUMENT Assessment of Kidney Function! Many toxic metals are nephrotoxic Agent-metal complexes excreted primarily through the kidneys Avoid acute renal failure! Assessment of Glomerular Filtration Serum creatinine (Cockcroft-Gault Equation) Elderly and others with very low muscle mass, serum creatinine alone inadequate/insensitive for detection of compromised GF Creatinine clearance: timed urine (6 h), and blood draw Arch Intern Med (2003)163:356 60 Doctor s Data 10

FDA Status of Agents Ca-Na 2 -EDTA: FDA approved in the 50s (Pb) Ca-Na 2 -EDTA Ca-Na 2 -EDTA: slow infusion/fast drip 50 mg/kg, not to exceed 3 gm T 1/2 about 30-45 minutes 6hr. urine collection DMSA Chemet : FDA approved for Pb poisoning in children in 1990 2,3-meso-dimercaptosuccinic acid Doctor s Data 11

DMSA General Does NOT brain Pb or Hg levels brain Pb and Hg levels (animal studies) Increases urinary Pb, Hg and As in humans, NOT Al, U or Tl Arch. Toxicol.(2002)76:437 31 Toxicol(1989)54:323 33 Toxicol (2002)177:186 97 Envir. Toxicol.(2001)9:173 84 Toxicol Appl Pharm(1999)161:283 93 Clinical Pharmacology: DMSA Oral: 20-25% absorbed, T 1/2α 4 hrs. Peak plasma 3 hrs., rate urinary excretion 4 hrs. Urinary excretion: 90% as mixed disulfides with 2 cysteines (1:2) J Nutr Envir Med(1998)8:219 31 PDR(2005) Toxicol(1995)97:23 38 J Pharmacol Exp Therap(1993)267:12 21 DMSA Challenge 20-30 mg DMSA/kg BW as oral bolus on empty stomach ( 2 gms) With hold food about 2 hrs. Encourage 0.5L fluid over next few hrs. Collect all urine for 6 hrs. J Nutr Envir Med (1998) 8:219 231 Doctor s Data 12

DMPS DMPS: Not FDA approved, available from compounding pharmacies 2,3-dimercaptopropane-1-sulfonic acid H H H H C C C SO 3-,Na + S S H H H (Informed consent!) Urinary Hg Before and After DMPS Challenge ug Hg / 6h Before Dental techs (10) 5 1 Dentists (5) 3 1 Controls (13) 1 0.2 After 424 ± 85 162 ±52 27 ±3 (300 mg DMPS oral) J Pharmacol Exp Ther (1995)272:264 74 DMPS Challenges IV: 3-5 mg/kg (250 mg max), slow push (5-10 min.) Oral: 10 mg /kg BW (5 mg/kg children), empty stomach (empty bladder) With hold food about 2 hrs. Encourage 0.5L fluid over next few hrs. Collect all urine for 6 hrs. Doctor s Data 13

Inexplicable Neuropathy 59 yo home maker, husband accountant Progressive, elusive peripheral neuropathy Doc checked for metal neurotoxic metal burden 40 mg/kg glycine (oral) DMSA (10 mg/kg) Pre-provocation Oral glycine, 10 mg/kg DMSA Doctor s Data 14

Glycine : Assisting Agent 40 mg/kg glycine orally ~ about 2 hrs. before provocation test Use in CONJUNCTION with agents ( logk- Hg; 9-13, Al; 8-10, Pb & Sb; 8-9) Not to be used alone Envir Hlth Perspect (1986)65:363 411 Pangborn(1995), DDI/Bionostics Quig, Townsend Letter, June 2007 Summary: Lab Tests Exposure (very recent or ongoing) Blood and unprovoked urine Hair (longer temporal window) Elevated RBC GSH (induced) Net retention Comparison of pre and post provoked urine Low RBC GSH (depleted) oxidized DNA damage ( urine 8-OHdG) Take Home Messages Assess status of liver & glomerular filtration. Apply pharmacokinetic facts. Do pre (1st AM) and post provocation urinalysis initially Remove source(s) of ongoing exposure. Monitor efficacy of detoxification: Repeat challenge after 5-10 treatments Doctor s Data 15

Metal 1 st Choice 2 nd Choice Hg, MeHg DMPSor DMSA Pb DMSA/EDTA DMPS As DMPS/EDTA DMSA Cd EDTA EDTA Sb, Sn DMPS/DMSA EDTA Pt, Ti DMPS EDTA Fe, Al EDTA DFO Tl Prussian Blue Toxicol (1995)97:23 38 Doctor s Data 16